Abbott Laboratories (ABT)

Currency in USD
108.52
+1.27(+1.18%)
Closed·
108.30-0.22(-0.20%)
·

ABT Earnings

Latest Release
Oct 21, 2026
EPS / Forecast
1.42 / 1.42
Revenue / Forecast
13.01B / 12.99B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/12--/1.64--/13.22B----Free Sign Up
2026/091.42/1.4213.01B/12.99B0%+0.15%Free Sign Up
2026/061.31/1.2812.59B/12.52B+2.34%+0.56%Free Sign Up
2026/031.15/1.1511.16B/11.00B0%+1.45%Free Sign Up
2025/121.50/1.5011.46B/11.80B0%-2.88%Free Sign Up
2025/090.940/1.3011.37B/11.40B-27.69%-0.26%Free Sign Up
2025/061.26/1.2511.42B/11.07B+0.8%+3.16%Free Sign Up
2025/030.760/1.0710.36B/10.40B-28.97%-0.38%Free Sign Up
2024/121.34/1.3410.97B/11.03B0%-0.54%Free Sign Up
2024/091.21/1.2010.60B/10.56B+0.83%+0.38%Free Sign Up

All numbers in USD

Abbott Laboratories Earnings Call Summary for Q3/2026

  • Abbott reported Q3 2026 adjusted EPS of $1.42, matching estimates, on revenue of $13.01B, slightly above forecasts; shares fell 2.69% to $99.69.
  • Company cut full-year comparable sales growth guidance to 6% due to softer expectations in electrophysiology and diabetes care businesses.
  • Abbott announced plans to spin off its nutrition business (Similac, Ensure, PediaSure) into standalone public company by end of 2026.
  • Q4 adjusted EPS guidance set at $1.62-$1.67 with sales growth expected just above 8%; management anticipates growth acceleration in 2027.
  • Gross margin expanded 140 bps to 57.2%; operating margin rose 40 bps to 23.4%, reflecting improved profitability across diversified portfolio.
Last Updated: 2026-10-21, 10:32 a/m
Read Full Transcript

FAQ

What Is Abbott's Earnings Per Share (TTM)?

The Abbott EPS (TTM) is 2.69.

When Is The Next Abbott Earnings Date?

Abbott will release its next earnings report on Jan 27, 2027.

What Is Abbott’s Revenue Forecasts For Upcoming Quarters?

Abbott’s revenue forecast is 13.22B.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.